Managing Cancer Grand Challenges funding
This page is for researchers funded through Cancer Grand Challenges, prospective and current applicants for funding, and their host institutions. Relevant contractual documentation and guidance for managing Cancer Grand Challenges funding can be found at the bottom of this page.
Full application webinar
Our full application webinar gives you the chance to learn about the full application process which closes on 26 October 2023. You can watch the recording below.
If you have any questions, please get in touch as soon as possible email at [email protected] or by phone on +44 (0) 20 3469 8855.
When receiving Cancer Grand Challenges funding, all investigators and institutions participating in a team are required to sign up to a Cancer Grand Challenges Award Agreement, also signed by the research funders: Cancer Research UK and the National Cancer Institute (NCI).
The Award Agreement incorporates the terms outlined in the Award Management and Funding Policy Guide, Commercialisation Policy, Cancer Research UK Allowable Costs Guidance and National Cancer Institute Other Transaction Award Policy Guide.You can access all of these documents below.
Each funded institution will also be subject to specific terms detailed in their Notice of Award and Grant Award Letter. All contractual documents may be updated from time to time, and the most up-to-date versions will be posted here.
This is the lead contracting document to be signed by all parties within a team
This document is a guide to the management of Cancer Grand Challenges awards starting in 2022 and beyond.
This document outlines the commercialisation process entered into by all parties
This document provides terms relevant only to the Cancer Research UK portion of funding
NCI will issue Cancer Grand Challenges awards to Institutions using the NIH Other Transaction (OT) Authority, granted under Section 402(n) of the Public Health Service Act. This document outlines terms specific to this.